Filing Details
- Accession Number:
- 0001209191-13-040859
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-08-15 15:07:20
- Reporting Period:
- 2013-08-14
- Filing Date:
- 2013-08-15
- Accepted Time:
- 2013-08-15 15:07:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 805928 | Axogen Inc. | AXGN | Electromedical & Electrotherapeutic Apparatus (3845) | 411301878 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1492710 | Gene Gregory Freitag | C/O Axogen, Inc. 13859 Progress Boulevard, Suite 100 Alachua FL 32615 | Cfo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-08-14 | 8,334 | $3.00 | 32,652 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The reporting person purchased these shares in its individual capacity and not through any directed share or other formal program in connection with an underwritten registered public offering of the Company. On August 9, the trade date for the public offering and the first day AxoGen shares were traded on the NASDAQ Capital Market, the closing sale price reported by NASDAQ was $2.98 per share. The public offering closed on August 14, 2013, and the closing sale price reported by NASDAQ on August 14, 2013 was $2.97 per share.
Billionaire Hedge Funds
